The absorption and disposition of inorganic cobalt salts alter oral adminis
tration have not been completely characterized. The objective of this proje
ct was to investigate the absorption and disposition of cobalt naphthenate
in Fischer 344 rats following a single oral dose. Cobalt naphthenate was gi
ven orally at 3 doses: 0.333, 3.33, or 33.3 mg Co(II)/kg. Tissues, urine, a
nd feces were collected over a 36-h period from the low- and high-dose grou
ps; blood was collected from all 3 dose groups. The majority of the dose in
both the low- and high-dose groups was excreted in the feces (42% and 73.1
%, respectively), indicating that cobalt was incompletely absorbed from the
gastrointestinal tract following oral dosing. The percent of the dose excr
eted in the urine was similar for low and high doses (31.8% and 26.3%, resp
ectively). Cobalt concentrations were found to be highest in the liver and
kidneys. The blood versus time cobalt concentration curves or the low-dose,
intermediate-dose, and high-dose groups were elevated 4- to 5-fold, 14- to
25-fold, and 25- to 60-fold over control blood levels, respectively. The p
eak plasma concentrations of 0.6 and 1.7 mu g Co(II)/ml occurred at approxi
mately 4.3 h for the intermediate-dose group, and 3.3 h for the high-dose g
roup. The terminal elimination half-lives were 24.7 and 24 h for the interm
ediate- and high-dose groups, respectively. Thus, although the extent of co
balt absorption as indicated by the blood concentrations and areas under th
e blood-time curves was not proportional to dole, the calculated pharmacoki
netic values for the time to peak blood concentration and the apparent elim
ination rate constants were independent of dose. The amount excreted in the
urine was also proportional to the dose. These apparent anomalies were not
related to protein binding in blood.